Skip to main content
. Author manuscript; available in PMC: 2014 Nov 26.
Published in final edited form as: Brain Disord Ther. 2014 Apr 5;3:1000119. doi: 10.4172/2168-975X.1000119

Figure 1.

Figure 1

General model of aging in FMRl premutation carriers. Normal aging processes, like telomere shortening, gerontogenesis etc., are exacerbated by FMRl toxicity across the whole lifespan of a premutation carrier.